| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |